These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12622951)

  • 1. [Hopes and experiences in the treatment of severe pulmonary hypertension].
    Monserrat L; Penas Lado M; Castro-Beiras A
    Rev Esp Cardiol; 2003 Mar; 56(3):228-9. PubMed ID: 12622951
    [No Abstract]   [Full Text] [Related]  

  • 2. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

  • 3. Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol.
    Kataoka M; Satoh T; Manabe T; Anzai T; Yoshikawa T; Mitamura H; Ogawa S
    Intern Med; 2004 Oct; 43(10):945-50. PubMed ID: 15575245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary arterial hypertension: combination therapy in the modern management era.
    Sitbon O
    Eur Respir Rev; 2010 Dec; 19(118):348-9. PubMed ID: 21119195
    [No Abstract]   [Full Text] [Related]  

  • 5. Bosentan for the treatment of portopulmonary hypertension.
    Tempe DK; Datt V; Datta D
    Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract]   [Full Text] [Related]  

  • 7. Sildenafil treatment of primary pulmonary hypertension.
    Laupland KB; Helmersen D; Zygun DA; Viner SM
    Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension: the race for the most effective treatment.
    McLaughin VV; Hoeper MM
    Am J Respir Crit Care Med; 2005 Jun; 171(11):1199-201. PubMed ID: 15914567
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-associated pulmonary hypertension: diagnosis and treatment.
    Burkart KM; Farber HW
    Adv Cardiol; 2003; 40():197-207. PubMed ID: 14533555
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination drug therapy in the management of pulmonary arterial hypertension.
    Kayser SR
    Prog Cardiovasc Nurs; 2005; 20(4):177-82. PubMed ID: 16276142
    [No Abstract]   [Full Text] [Related]  

  • 11. Sildenafil as a treatment for pulmonary hypertension.
    Carroll WD; Dhillon R
    Arch Dis Child; 2003 Sep; 88(9):827-8. PubMed ID: 12937112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pulmonary arterial hypertension.
    Humbert M; Sitbon O; Simonneau G
    N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of rebound pulmonary hypertension: why not sildenafil?
    Raja SG
    Anesthesiology; 2004 Dec; 101(6):1480; author reply 1481. PubMed ID: 15564966
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in pulmonary vascular disease.
    Adatia I
    Curr Opin Pediatr; 2002 Jun; 14(3):292-7. PubMed ID: 12011667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.
    Abrams D; Schulze-Neick I; Magee AG
    Heart; 2000 Aug; 84(2):E4. PubMed ID: 10908271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
    Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
    Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
    Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
    Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation.
    Saggar R; Shapiro SS; Ross DJ; Fishbein MC; Zisman DA; Lynch JP; Weigt SS; Ardehali A; Belperio JA; Saggar R
    J Heart Lung Transplant; 2009 Sep; 28(9):964-7. PubMed ID: 19716051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked improvement with sildenafil in a patient with idiopathic pulmonary arterial hypertension unresponsive to beraprost and sarpogrelate.
    Kawano H; Sengyoku H; Satoh O; Urabe S; Koide Y; Yano K
    Intern Med; 2007; 46(12):893-8. PubMed ID: 17575385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary pulmonary hypertension: prospects for treatment].
    Sáenz de la Calzada C
    Med Clin (Barc); 2004 Jan; 122(2):62-3. PubMed ID: 14733858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.